Viewing StudyNCT00225056



Ignite Creation Date: 2024-05-05 @ 12:03 PM
Last Modification Date: 2024-10-26 @ 9:19 AM
Study NCT ID: NCT00225056
Status: TERMINATED
Last Update Posted: 2007-04-20
First Post: 2005-09-21

Brief Title: Phase II Study of Capecitabine and Weekly Docetaxel Followed by Capecitabine Maintenance for Patients With Metastatic Breast Carcinoma
Sponsor: Oncology Specialties Alabama
Organization: Oncology Specialties Alabama

Conditions & Keywords Data

Conditions:
Name
Metastatic Breast Cancer
Keywords: